SCHEMBL7797805

SCHEMBL7797805

Cc1ccc(CCC(=O)N(C)C)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TRPM8 Q7Z2W7 1/20 0.49
KMT2A Q03164 2/20 0.49
SLC5A1 P13866 1/20 0.49
SLC5A2 P31639 1/20 0.49
CCR9 P51686 1/20 0.48
ALDH1A1 P00352 2/20 0.45
HTT P42858 1/20 0.45
PLAAT3 P53816 1/20 0.45
PLAAT5 Q96KN8 1/20 0.45
PLAAT2 Q9NWW9 1/20 0.45
PLAAT4 Q9UL19 1/20 0.45
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2A6 P11509 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9394272 0.89 ALOX5 (0.54) FFAR1TDP1L3MBTL1TRPM8SLC5A1
SCHEMBL16416582 0.84 ESR1 (0.50) FFAR1TDP1L3MBTL1KMT2ASLC5A1
SCHEMBL11132861 0.82 RAB9A (0.51) FFAR1KMT2ACCR9ALDH1A1HTT
SCHEMBL3139297 0.82 TAAR1 (0.52) FFAR1KMT2ATAAR1
SCHEMBL9242991 0.82 GFER (0.48) FFAR1L3MBTL1KMT2AHTT
SCHEMBL4425976 0.82 TAAR1 (0.52) FFAR1TDP1KMT2ASLC5A1SLC5A2
SCHEMBL21246195 0.82 L3MBTL1 (0.46) FFAR1TDP1L3MBTL1TRPM8KMT2A
SCHEMBL3366949 0.82 KMT2A (0.70) FFAR1TDP1L3MBTL1KMT2AALDH1A1
Water SCHEMBL3678915 0.80 KMT2A (0.68) FFAR1TDP1L3MBTL1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL3136984 0.80 KMT2A (0.68) FFAR1TDP1L3MBTL1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114736134-B (R) -beta-hydroxyaryl propionamide derivative and preparation method thereof 浙江工业大学台州研究院 2023-06-06 CN disclosed
CN-111960962-B Nickel-catalyzed alpha-alkylation method of acetamide and thioacetamide 山东师范大学 2023-03-07 CN disclosed
CN-114736134-A (R) -beta-hydroxyaryl propionamide derivative and preparation method thereof 浙江工业大学台州研究院 2022-07-12 CN disclosed
CN-111960962-A Nickel-catalyzed alpha-alkylation method of acetamide and thioacetamide 山东师范大学 2020-11-20 CN disclosed
EP-2655357-B1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO SA (CH) 2016-06-22 EP disclosed
US-20130109652-A1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS ADDEX PHARMACEUTICALS S.A. (CH) 2013-05-02 US disclosed
US-20130109652-A1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS ADDEX PHARMACEUTICALS S.A. (CH) 2013-05-02 US disclosed
US-8399493-B2 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors Janssen Pharmaceuticals, Inc. (US) 2013-03-19 US disclosed
EP-1523473-B1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2013-02-27 EP disclosed
WO-2012084704-A1 INDAZOLYL TRIAZOLE DERIVATIVES AS IRAK INHIBITORS MERCK SERONO S.A. (CH) 2012-06-28 WO disclosed
US-20070213323-A1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS Janssen Pharmaceuticals, Inc. 2007-09-13 US disclosed
EP-0814382-B1 Improved photoresists and method for making printing plates PRINTING DEV INC (US) 2001-11-28 EP disclosed
US-5962192-A FILM FORMING POLYMER, AN ORGANO AZIDE AND A PHOTOSENSITIVE DYE THAT ABSORBS LIGHT AT THE FREQUENCY OF THE PATTERNING LASER AND CONVERTS IT TO HEAT ENERGY. THE HEAT ENERGY IN TURN ELEVATES THE TEMPERATURE OF THE ORGANO AZIDE ABOVE ITS PRINTING DEVELOPMENTS, INC. (US) 1999-10-05 US disclosed
EP-0814382-A1 Improved photoresists and method for making printing plates PRINTING DEVELOPMENTS INC (US) 1997-12-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213323-A1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS GRM2, GRM1, GRM3 FFAR1 162/4885TDP1 2586/4885L3MBTL1 4718/4885
US-20130109652-A1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS GRM2, GRM1, GRIA2 FFAR1 169/4885TDP1 3094/4885L3MBTL1 4818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.